BCAN and Alzheimer disease: PNNs have been found to be largely unaffected in the Tg2576 mouse model of AD when using both aggrecan immunoreactivity and WFA staining; however, in the APP/PS1 tg mouse, total protein levels of neurocan, brevican, and tenascin-R are increased as is the number of WFA-labeled PNNs [46].